In other recent news, Colgate-Palmolive Company reported its financial results for the first quarter of 2025, revealing a slight miss on earnings per share (EPS) but exceeding revenue forecasts. The company posted an EPS of $0.85, falling short of the expected $0.87, while revenue reached $4.91 billion, surpassing the forecast of $4.89 billion. Goldman Sachs maintained its Buy rating on Colgate-Palmolive with a price target of $106.00, citing the strong performance of the Hill's Pet Nutrition segment as a key growth driver. Piper Sandler also reiterated its Overweight rating and $109.00 price target, highlighting the company's stable business practices and shareholder value focus.